Kasel JA - Search Results

1

Risk of primary infection and reinfection with respiratory syncytial virus.

Glezen WP, Taber LH, Frank AL, Kasel JA. Glezen WP, et al. Among authors: kasel ja. Am J Dis Child. 1986 Jun;140(6):543-6. doi: 10.1001/archpedi.1986.02140200053026. Am J Dis Child. 1986. PMID: 3706232

2

Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children.

Glezen WP, Frank AL, Taber LH, Kasel JA. Glezen WP, et al. Among authors: kasel ja. J Infect Dis. 1984 Dec;150(6):851-7. doi: 10.1093/infdis/150.6.851. J Infect Dis. 1984. PMID: 6094674

3

Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection.

Piedra PA, Glezen WP, Kasel JA, Welliver RC, Jewel AM, Rayford Y, Hogerman DA, Hildreth SW, Paradiso PR. Piedra PA, et al. Among authors: kasel ja. Vaccine. 1995 Aug;13(12):1095-101. doi: 10.1016/0264-410x(95)00034-x. Vaccine. 1995. PMID: 7491817 Clinical Trial.

4

Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children.

Kasel JA, Walsh EE, Frank AL, Baxter BD, Taber LH, Glezen WP. Kasel JA, et al. Viral Immunol. 1987-1988;1(3):199-205. doi: 10.1089/vim.1987.1.199. Viral Immunol. 1987. PMID: 3509676

5

Description of an adenovirus type 8 outbreak in hospitalized neonates born prematurely.

Piedra PA, Kasel JA, Norton HJ, Garcia-Prats JA, Rayford Y, Estes MK, Hull R, Baker CJ. Piedra PA, et al. Among authors: kasel ja. Pediatr Infect Dis J. 1992 Jun;11(6):460-5. doi: 10.1097/00006454-199206000-00008. Pediatr Infect Dis J. 1992. PMID: 1608683

6

Evaluation of an intravenous immunoglobulin preparation for the prevention of viral infection among hospitalized low birth weight infants.

Piedra PA, Kasel JA, Norton HJ, Gruber WC, Garcia-Prats JA, Baker CJ. Piedra PA, et al. Among authors: kasel ja. Pediatr Infect Dis J. 1990 Jul;9(7):470-5. doi: 10.1097/00006454-199007000-00004. Pediatr Infect Dis J. 1990. PMID: 2164655 Clinical Trial.

7

Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine.

Zahradnik JM, Kasel JA, Martin RR, Six HR, Cate TR. Zahradnik JM, et al. Among authors: kasel ja. J Med Virol. 1983;11(4):277-85. doi: 10.1002/jmv.1890110403. J Med Virol. 1983. PMID: 6875521

8

Molecular cloning and sequence determination of the fusion protein gene of human parainfluenza virus type 1.

Merson JR, Hull RA, Estes MK, Kasel JA. Merson JR, et al. Among authors: kasel ja. Virology. 1988 Nov;167(1):97-105. doi: 10.1016/0042-6822(88)90058-x. Virology. 1988. PMID: 2847427

9

Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children.

Kasel JA, Frank AL, Keitel WA, Taber LH, Glezen WP. Kasel JA, et al. J Virol. 1984 Dec;52(3):828-32. doi: 10.1128/JVI.52.3.828-832.1984. J Virol. 1984. PMID: 6092715 Free PMC article.

10

Immunity to influenza in man.

Couch RB, Kasel JA. Couch RB, et al. Among authors: kasel ja. Annu Rev Microbiol. 1983;37:529-49. doi: 10.1146/annurev.mi.37.100183.002525. Annu Rev Microbiol. 1983. PMID: 6357060 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results